 |
|
Mammalian target of rapamycin inhibition in polycystic kidney disease: From bench to bedside
Hyun-Jung Kim, Charles L. Edelstein
Kidney Res Clin Pract. 2012;31(3):132-138. Published online 2012 Aug 10 DOI: https://doi.org/10.1016/j.krcp.2012.07.002
|
|
Citations to this article as recorded by
 Ablation of Long Noncoding RNA Hoxb3os Exacerbates Cystogenesis in Mouse Polycystic Kidney Disease
Ivan Weisser, Kara Eckberg, Stephen D'Amico, Daniel Buttram, Karam Aboudehen
Journal of the American Society of Nephrology.2024; 35(1): 41. CrossRef Mechanism of cystogenesis by Cd79a-driven, conditional mTOR activation in developing mouse nephrons
Linh Tran Nguyen Truc, Satoshi Matsuda, Akiko Takenouchi, Quynh Tran Thuy Huong, Yui Kotani, Tatsuhiko Miyazaki, Hiroaki Kanda, Katsuhiko Yoshizawa, Hiroyasu Tsukaguchi
Scientific Reports.2023;[Epub] CrossRef Crosstalk between cilia and autophagy: implication for human diseases
Manuela Morleo, Helena L.A. Vieira, Petra Pennekamp, Alessandro Palma, Liliana Bento-Lopes, Heymut Omran, Susana S. Lopes, Duarte C. Barral, Brunella Franco
Autophagy.2023; 19(1): 24. CrossRef Folate conjugated nanomedicines for selective inhibition of mTOR signaling in polycystic kidneys at clinically relevant doses
Rajasekharreddy Pala, Ayan K. Barui, Ashraf M. Mohieldin, Jing Zhou, Surya M. Nauli
Biomaterials.2023; 302: 122329. CrossRef Molecular Mechanisms of Epigenetic Regulation, Inflammation, and Cell Death in ADPKD
Ewud Agborbesong, Linda Xiaoyan Li, Lu Li, Xiaogang Li
Frontiers in Molecular Biosciences.2022;[Epub] CrossRef Adult dominant polycystic kidney disease: A prototypical disease for pharmanutrition interventions
Maria Serena Lonardo, Bruna Guida, Nunzia Cacciapuoti, Mariastella Di Lauro, Mauro Cataldi
PharmaNutrition.2022; 20: 100294. CrossRef Resident Macrophages in Cystic Kidney Disease
Zhang Li, Kurt A. Zimmerman, Bradley K. Yoder
Kidney360.2021; 2(1): 167. CrossRef The PI3K/Akt/mTOR pathway in polycystic kidney disease: A complex interaction with polycystins and primary cilium
Jean Piero Margaria, Carlo Cosimo Campa, Maria Chiara De Santis, Emilio Hirsch, Irene Franco
Cellular Signalling.2020; 66: 109468. CrossRef TAZ/Wnt-β-catenin/c-MYC axis regulates cystogenesis in polycystic kidney disease
Eun Ji Lee, Eunjeong Seo, Jin Won Kim, Sun Ah Nam, Jong Young Lee, Jaehee Jun, Sumin Oh, Minah Park, Eek-hoon Jho, Kyung Hyun Yoo, Jong Hoon Park, Yong Kyun Kim
Proceedings of the National Academy of Sciences.2020; 117(46): 29001. CrossRef Targeting and therapeutic peptide-based strategies for polycystic kidney disease
Jonathan Wang, Nirmalya Tripathy, Eun Ji Chung
Advanced Drug Delivery Reviews.2020; 161-162: 176. CrossRef iTRAQ-based phosphoproteomic analysis reveals host cell's specific responses to Toxoplasma gondii at the phases of invasion and prior to egress
Cheng He, Ling Kong, Santhosh Puthiyakunnon, Hai-Xia Wei, Li-Juan Zhou, Hong-Juan Peng
Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics.2019; 1867(3): 202. CrossRef Recent Advances of mTOR Inhibitors Use in Autosomal Dominant Polycystic Kidney Disease: Is the Road Still Open?
Pei Kou, Shuang Wei , Fei Xiong
Current Medicinal Chemistry.2019; 26(16): 2962. CrossRef Casein kinase 1ε and 1α as novel players in polycystic kidney disease and mechanistic targets for (R)-roscovitine and (S)-CR8
Katy Billot, Charlène Coquil, Benoit Villiers, Béatrice Josselin-Foll, Nathalie Desban, Claire Delehouzé, Nassima Oumata, Yannick Le Meur, Alessandra Boletta, Thomas Weimbs, Melanie Grosch, Ralph Witzgall, Sophie Saunier, Evelyne Fischer, Marco Pontoglio,
American Journal of Physiology-Renal Physiology.2018; 315(1): F57. CrossRef Comparison of folate-conjugated rapamycin versus unconjugated rapamycin in an orthologous mouse model of polycystic kidney disease
Kevin R. Kipp, Samantha L. Kruger, Margaret F. Schimmel, Nikki Parker, Jonathan M. Shillingford, Christopher P. Leamon, Thomas Weimbs
American Journal of Physiology-Renal Physiology.2018; 315(2): F395. CrossRef Emerging targeted strategies for the treatment of autosomal dominant polycystic kidney disease
Thomas Weimbs, Jonathan M Shillingford, Jacob Torres, Samantha L Kruger, Bryan C Bourgeois
Clinical Kidney Journal.2018; 11(suppl_1): i27. CrossRef Roles of mTOR complexes in the kidney: implications for renal disease and transplantation
Daniel Fantus, Natasha M. Rogers, Florian Grahammer, Tobias B. Huber, Angus W. Thomson
Nature Reviews Nephrology.2016; 12(10): 587. CrossRef
|